SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

$WAGMI is a community-driven meme token built on the Solana blockchain, designed to bring positivity, unity, and humor into the crypto space. The project encourages community engagement through memes, social interaction, and token-based activities. It leverages Solana’s fast and low-cost infrastructure to allow for smooth on-chain interactions, such as token transfers, community games, and NFT integration. The goal is to foster a fun, inclusive ecosystem where holders feel they are part of a larger movement – "We Are Gonna Make It."

WAGMI

WAGMI is trending as community members express strong conviction and highlight its price stability within the Solana ecosystem. Discussions also focus on WAGMI's potential for significant revaluation, drawing comparisons to other successful meme coins like DOGE and SHIB. The community emphasizes WAGMI's organic growth and potential for long-term gains, with some anticipating a major breakout.

WISeKey International Holding Ltd. is a cybersecurity company, which engages in offering digital security technology solutions. The firm operates through the Internet of Things (IoT), and Managed Public Key Infrastructure (mPKI) segments. The IoT segment refers to the design, manufacturing, sales and distribution of microprocessors operations. The mPKI segment includes all operations relating to the provision of secured access keys, authentication, signing software, certificates and digital security applications. The company was founded by Joao Carlos Creus Moreira and Philippe Doubre in 1999 and is headquartered in Zug, Switzerland.

WISeKey International Holding Ltd - ADR

WISeKey is trending as investors discuss its potential upside in the post-quantum computing era, particularly in securing satellite constellations. The community is highlighting the company's subsidiaries, including SEALCOIN and WISeSat, and comparing its market cap to its parent company, LAES.  Some investors believe WKEY's current valuation doesn't reflect the value of its assets and potential growth in the quantum security market.

The SolyCat is a symbol of energy and mystery. Shining like the sun and agile as a feline.  Solycat is here to take over Solana! Inspired by Shiba Inu’s legendary rise on Ethereum, Solycat is the ultimate meme coin designed for Solana’s fast and scalable blockchain.  Our mission is simple: become the top cat of Solana. With bold branding, a vibrant community, and unstoppable momentum, Solycat is ready to dominate. This isn’t just another token—it’s a movement powered by fun, creativity, and the spirit of decentralization.  Join the pride and let’s make history, one paw at a time!

Solycat

Solycat ($SOLYCAT) is gaining attention as a new Solana-based token, particularly following its availability on Phantom Wallet. The community is using feline-themed puns while highlighting the token's potential for gains. Some users are noting its relative stability compared to the broader market.

Why Queen Kitty ($QKitty) Is The Meme Token You’ve Been Waiting For  Queen Kitty isn’t just another hype project—this is a real movement with substance and community power!  Why hold $QKitty? 😼 Real dev, real builds: No fake teams, no copy-paste code. Everything you see is made from scratch. 💧 Working Faucet: Free QKitty for the community. Want to know how? Just ask! 🏆 Big Buy Competition Bot: See top buyers live, fight for the throne, and win rewards! 🎮 Multi-token P2E game coming soon: Play and earn across Web, iOS, Android! 🐾 NFT collecting soon: Cutest collection in crypto, bringing perks and more ways to earn.  Queen Kitty means innovation, transparency, and real delivery for holders. Curious? Join the chat and ask anything!  $QKitty: By the community, for the community. To the moon, together! 🚀🐱

Queen Kitty

Queen Kitty ($QKITTY) is trending amid community excitement surrounding its trading bot, which some users claim generates daily interest. Chatter also mentions upcoming updates and a potential decentralized exchange (DEX) launch, with some users highlighting airdrops related to $BROKE.

Vanguard Group, Inc. - Vanguard Total Stock Market ETF

Vanguard Total Stock Market ETF

VTI is trending amid discussions around political and economic factors, including tariffs and government shutdowns, and their potential impact on the market. Community members are expressing concerns about inflation, economic stability, and potential market corrections. Recent news articles highlight company-specific updates, AI developments, and broader economic trends, contributing to the ongoing conversation around VTI.

Syndax Pharmaceuticals, Inc. engages in the development of cancer therapies. Its products include SyndAccess, Revuforj, Niktimvo, and IncyteCARES. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in New York, NY.

Syndax Pharmaceuticals Inc

SNDX is trending as the market anticipates the FDA's decision on their supplemental NDA for Revuforj to treat a specific type of leukemia, expected by October 25th. The community is weighing the potential for label expansion and increased market access against existing concerns around boxed warnings and competitor drugs. Some traders believe that approval is already priced in, while others anticipate a significant surge depending on the scope of the label.

MaxsMaking, Inc. is a holding company, which engages in the manufacture of customized consumer goods. It offers a range of customizable textile products, including backpacks, thermal bags, canvas bags, aprons, throw pillows, flags, and advertising chair covers. The company was founded by Xiao Zhong Lin and Xue Fen Zhang in January 2007 and is headquartered in Shanghai, China.

MaxsMaking Inc. - Ordinary Shares - Class A

MaxsMaking Inc. Class A Ordinary Shares

MaxsMaking Inc. ($MAMK) is trending due to discussions around its low float and potential for significant price movement, with some traders drawing comparisons to other stocks that have experienced similar runs. Community members are actively debating trading strategies and entry points, while also expressing concerns about halts and potential manipulation given its Chinese origins and textile business.

Solana is a highly functional open source project that banks on blockchain technology’s permissionless nature to provide decentralized finance (DeFi) solutions. It is a layer 1 network that offers fast speeds and affordable costs. While the idea and initial work on the project began in 2017, Solana was officially launched in March 2020 by the Solana Foundation with headquarters in Geneva, Switzerland.

Solana

Solana is trending as the community discusses its potential for growth and new projects being built on the platform, including meme coins like $SOLYCAT and $CAW. Community members are also closely watching for potential breakout opportunities, emphasizing the importance of conviction and holding through market volatility. Recent news of Fidelity adding Solana support and institutional validation may be contributing to the positive sentiment.

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The Corporate segment includes general and administrative overhead expenses. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Adma Biologics Inc

ADMA Biologics is trending due to concerns surrounding a recent FDA safety communication regarding allergic reactions to specific lots of its BIVIGAM and ASCENIV products, leading to a stock price drop. While some investors view this as a temporary setback and potential buying opportunity, citing the company's strong financials and growth prospects, others worry about the impact of potential voluntary recalls on revenue and profitability. The community is also discussing the CEO's recent stock sale and speculating about potential short selling or manipulation.

SSgA Active Trust - SPDR Dow Jones Industrial Average ETF

DIA is trending as investors weigh Trump's tariff threats against China and their potential impact, with some analysts suggesting it's a negotiation tactic. Community members are discussing the possibility of a market correction and analyzing technical indicators. Broader discussions involve the health of regional banks and the potential effects of rising interest rates.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Curis (CRIS) Reports Q2 Loss, Beats Revenue Estimates

Curis (CRIS) delivered earnings and revenue surprises of +65.83% and +14.54%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Curis Announces Additional Data from TakeAim Leukemia Study

Curis Announces Additional Data from TakeAim Leukemia Study Curis Announces Additional Data from TakeAim Leukemia Study PR Newswire LEXINGTON, Mass., Dec. 10, 2024 LEXINGTON, Mass., Dec. 10, 2024...

Curis Provides Third Quarter 2024 Business Update

Curis Provides Third Quarter 2024 Business Update Curis Provides Third Quarter 2024 Business Update PR Newswire LEXINGTON, Mass., Nov. 14, 2024 Management to host conference call today at 8:30 a.m...

Curis to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on November 14, 2024

Curis to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on November 14, 2024 Curis to Report Third Quarter 2024 Financial and Operating Results and...

Curis Announces $12.1 Million Registered Direct and Concurrent Private Placement

Curis Announces $12.1 Million Registered Direct and Concurrent Private Placement Curis Announces $12.1 Million Registered Direct and Concurrent Private Placement PR Newswire LEXINGTON, Mass., Oct...

Curis Announces the 3rd Annual Symposium on IRAK4 in Cancer

Curis Announces the 3rd Annual Symposium on IRAK4 in Cancer Curis Announces the 3rd Annual Symposium on IRAK4 in Cancer PR Newswire LEXINGTON, Mass., Sept. 23, 2024 Symposium hosted by Eric S. Winer...

Curis to Participate at the Upcoming 2024 Cantor Fitzgerald Global Healthcare Conference

Curis to Participate at the Upcoming 2024 Cantor Fitzgerald Global Healthcare Conference Curis to Participate at the Upcoming 2024 Cantor Fitzgerald Global Healthcare Conference PR Newswire...

Curis to Present at Upcoming Healthcare Conferences in September

Curis to Present at Upcoming Healthcare Conferences in September Curis to Present at Upcoming Healthcare Conferences in September PR Newswire LEXINGTON, Mass., Sept. 4, 2024 LEXINGTON, Mass., Sept...

Curis to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on August 1, 2024

Curis to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on August 1, 2024 Curis to Report Second Quarter 2024 Financial and Operating Results and Host...

Curis to Present at Upcoming Healthcare Conference in July

Curis to Present at Upcoming Healthcare Conference in July Curis to Present at Upcoming Healthcare Conference in July PR Newswire LEXINGTON, Mass., July 10, 2024 LEXINGTON, Mass., July 10, 2024...

Curis, Inc. engages in the development and commercialization of drug candidates for the treatment of human cancers. Its pipeline includes CUDC-907, CA-4948, CA-170 and CA-327. The CUDC-907 pipeline is an orally available small molecule inhibitor of HDAC and PI3K enzymes. The CA-170 pipeline is an also an orally-available small molecule antagonist of PD-L1 and VISTA immune checkpoints. The company was founded on February 14, 2000 and is headquartered in Lexington, MA.

Curis Inc

Cut 25 bps

Cut 50+ bps

No change

What will the Fed decide at its October meeting? Polymarket gives a 92% chance of a 25 bps cut. 
 
*Powered by Polymarket

Current Price	N/A
Prev Close	N/A
Open	N/A
Dividend Yield	0.00%
50-Day Moving Average	$1.65
Beta	0.91
Avg. Volume	70,076.19
PE Ratio	-0.33

52-Week High	$5.05
52-Week Low	$1.02
Market Capitalization	$20.12M
EPS (Annual)	-$6.88
Price to Book	-1.23
Revenue Per Employee	$320,823.53
Enterprise Value/EBITDA	N/A

CRIS
Curis Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CRIS News

CRISCuris Inc